Quidel Corporation (QDEL)
After hours:
| Previous close | 42.68 |
| Open | 42.65 |
| Bid | 43.58 x 100 |
| Ask | 43.68 x 200 |
| Day's range | 41.25 - 44.85 |
| 52-week range | 37.78 - 90.45 |
| Volume | |
| Avg. volume | 1,242,869 |
| Market cap | 2.917B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.15 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 59.00 |
Insider MonkeyQuidelOrtho Corporation (NASDAQ:QDEL) Q1 2024 Earnings Call Transcript
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2024 Earnings Call Transcript May 8, 2024 QuidelOrtho Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the QuidelOrtho First Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are […]
- GuruFocus.com
QuidelOrtho Corp (QDEL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
Despite a revenue dip, QuidelOrtho outlines robust strategies for recovery and growth under new leadership.
Business WireQuidelOrtho Reports First Quarter 2024 Financial Results
SAN DIEGO, May 08, 2024--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, today announced financial results for the first quarter ended March 31, 2024.
